文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Pharmacotherapy and metabolic/bariatric surgery: either or both?

作者信息

Finer Nick

机构信息

University College London, Cambridge, UK.

出版信息

Int J Obes (Lond). 2025 Aug 30. doi: 10.1038/s41366-025-01897-0.

DOI:10.1038/s41366-025-01897-0
PMID:40885860
Abstract
摘要

相似文献

[1]
Pharmacotherapy and metabolic/bariatric surgery: either or both?

Int J Obes (Lond). 2025-8-30

[2]
Effectiveness of Pharmacotherapy and Technical Modifications as Adjunctive Tools for Enhancing Weight Loss After Bariatric Endoscopy (Endoscopic Gastric Remodeling and Transoral Outlet Reduction): A Meta-analysis.

Obes Surg. 2025-7-11

[3]
Preoperative assessment and prehabilitation in patients with obesity undergoing non-bariatric surgery: A systematic review.

J Clin Anesth. 2022-6

[4]
Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities.

J Natl Cancer Inst Monogr. 2023-5-4

[5]
The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.

Int J Obes (Lond). 2015-11

[6]
Feasibility and short-term results of bariatric destination care: experience from a single Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program-accredited center.

Surg Obes Relat Dis. 2025-7-31

[7]
Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.

EClinicalMedicine. 2025-5-11

[8]
Pharmacotherapy before and after bariatric surgery.

Metabolism. 2023-11

[9]
Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity.

Surg Obes Relat Dis. 2025-3

[10]
Pre-surgical factors related to latent trajectories of 5-year weight loss for a diverse bariatric surgery population.

Surg Obes Relat Dis. 2024-7

本文引用的文献

[1]
Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue.

Mol Metab. 2025-5

[2]
Insights into the neurobiology of weight loss after bariatric surgery and GLP-1R agonists.

Neuropharmacology. 2025-3-1

[3]
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Br J Surg. 2024-11-27

[4]
The benefits of GLP-1 drugs beyond obesity.

Science. 2024-7-19

[5]
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity.

Drugs. 2024-8

[6]
Medium and Long-Term Weight Loss After Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis.

Obes Surg. 2024-5

[7]
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.

JAMA Surg. 2023-10-1

[8]
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.

Obes Surg. 2022-10

[9]
The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux-en-Y Gastric Bypass Surgery.

Obesity (Silver Spring). 2020-6

[10]
Primary and Secondary Nonresponse Following Bariatric Surgery: a Survey Study in Current Bariatric Practice in the Netherlands and Belgium.

Obes Surg. 2020-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索